Stephanie Gamez

Director, Research & Development Agragene

Dr. Stephanie Gamez, Director of R&D at Agragene is advancing the industry’s first gene editing pgSIT technology for insect pest control that is currently being reviewed by U.S. regulatory agencies. Agragene is targeting commercialization in 2027 under the brand KNOCKOUT SWD. Dr. Gamez has led technical proof of concept of pgSIT in the Spotted Wing Drosophila and is currently managing collaborations with universities for in-field trials of KNOCKOUTTM SWD across various geographies and fresh berry and cherry crops. Stephanie obtained her doctorate from the University of California, San Diego where she developed synthetic genetic control systems for mosquito control. Dr. Gamez’s hobbies include illustrating science, spending time with her family, and cats.

Seminars

Wednesday 25th March 2026
Panel Discussion: Integrating Genetics & IPM in Real-World Deployments
12:00 pm
  • Evaluating risk and benefit from the grower perspective to support adoption
  • Designing stewardship to prevent resistance breakdown and protect longevity
Wednesday 25th March 2026
Deploying Sterile Insect Technologies for Precision Crop Protection
11:30 am
  • Demonstrating field trial outcomes showing distance-based protection effects in Michigan
  • US EPA Section 3 registration and scaling regulatory engagement for commercial readiness
  • Collaborating with commercial insectaries to expand trial capacity and accelerate 2027 launch plans
Steph Gamez - 8th CRISPR AgBio Congress 2026